Free Trial

Kubient (KBNT) Competitors

Kubient logo

KBNT vs. KLDO, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, AUROW, AVPTW, BNIXW, and BNIXR

Should you be buying Kubient stock or one of its competitors? The main competitors of Kubient include Kaleido Biosciences (KLDO), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), Aurora Innovation (AUROW), AvePoint (AVPTW), Bannix Acquisition (BNIXW), and Bannix Acquisition (BNIXR). These companies are all part of the "computer software" industry.

Kubient vs.

Kaleido Biosciences (NASDAQ:KLDO) and Kubient (NASDAQ:KBNT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Kubient N/A N/A N/A

In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Kubient'saverage media sentiment score.

Company Overall Sentiment
Kaleido Biosciences Neutral
Kubient Neutral

81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 13.9% of Kubient shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 22.3% of Kubient shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Kaleido Biosciences received 49 more outperform votes than Kubient when rated by MarketBeat users. However, 71.43% of users gave Kubient an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote.

CompanyUnderperformOutperform
Kaleido BiosciencesOutperform Votes
54
57.45%
Underperform Votes
40
42.55%
KubientOutperform Votes
5
71.43%
Underperform Votes
2
28.57%

Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500. Comparatively, Kubient has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.

Kubient has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.04-$95.48M-$2.240.00
Kubient$1.17M0.00-$13.62MN/AN/A

Summary

Kubient beats Kaleido Biosciences on 5 of the 7 factors compared between the two stocks.

Remove Ads
Get Kubient News Delivered to You Automatically

Sign up to receive the latest news and ratings for KBNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KBNT vs. The Competition

MetricKubientComputer integrated systems design IndustryBusiness SectorNASDAQ Exchange
Market Cap$1,000.00$3.40B$7.03B$7.68B
Dividend YieldN/A2.20%2.53%4.02%
P/E RatioN/A60.4329.4918.55
Price / SalesN/A23.56143.3588.66
Price / CashN/A34.8531.4034.64
Price / BookN/A4.684.604.11
Net Income-$13.62M$38.20M$195.05M$247.18M

Kubient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KBNT
Kubient
N/AN/AN/AN/A$1,000.00$1.17M0.0040
KLDO
Kaleido Biosciences
N/A$0.00
flat
N/AN/A$4,000.00$1.10M0.0080
ALFIW
Alfi
N/AN/AN/AN/A$0.00$200,684.000.0040
APCXW
AppTech Payments
N/A$0.19
+25.0%
N/A-42.4%$0.00$365,000.000.0020
ARBEW
Arbe Robotics
N/A$0.27
-2.6%
N/A+25.4%$0.00$768,000.000.00120Short Interest ↑
Positive News
AOGOW
Arogo Capital Acquisition
N/A$0.03
-71.0%
N/AN/A$0.00N/A0.00N/A
AOGOU
Arogo Capital Acquisition
N/A$8.50
flat
N/AN/A$0.00N/A0.00N/A
AUROW
Aurora Innovation
N/A$1.63
+9.9%
N/A+429.6%$0.00$2M0.001,700Short Interest ↑
Gap Up
AVPTW
AvePoint
N/A$5.11
+8.3%
N/A+373.0%$0.00$330.48M0.001,930Gap Up
BNIXW
Bannix Acquisition
N/A$0.02
flat
N/AN/A$0.00N/A0.003
BNIXR
Bannix Acquisition
N/A$0.14
+24.4%
N/AN/A$0.00N/A0.003Gap Up
Remove Ads

Related Companies and Tools


This page (NASDAQ:KBNT) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners